Dr. Rob Sahr Discusses CAFC Ruling in Cleveland Clinic Case

Rob Sahr was quoted in the recent IP Watchdog article "Latest CAFC Ruling in Cleveland Clinic Case Confirms That USPTO’s 101 Guidance Holds Little Weight."

From the article:

“Although the Federal Circuit has recently blessed the patent-eligibility of claims reciting methods of treatment that appear to derive inventiveness from the detection of biomarkers, the decision in Cleveland Clinic leaves companies that develop diagnostic tests based on biomarkers with fewer options to protect their valuable intellectual property. This doesn’t necessarily leave companies without any options, but we expect the landscape for these types of filings to become significantly more sophisticated.” - Dr. Rob Sahr, Counsel at Choate Hall & Stewart.

Read the full article, here.